Related Experiment Video
Updated: Aug 8, 2026

09:37
Helminth Collection and Identification from Wildlife
Published on: December 14, 2013
Human fascioliasis in Shropshire
British Medical Journal
|August 29, 1970
Summary
Fascioliasis patients experienced malaise and pain. Oral bithionol effectively treated four patients, and the double diffusion precipitin test aided diagnosis. Wild watercress was identified as the infection source.
Area of Science:
- Parasitology
- Infectious Diseases
- Clinical Medicine
Background:
- Fascioliasis is a parasitic liver disease caused by Fasciola species.
- Clinical presentation can include gastrointestinal symptoms, fever, and eosinophilia.
- Accurate diagnosis and effective treatment are crucial for patient outcomes.
Purpose of the Study:
- To report on the clinical presentation of fascioliasis in five patients.
- To evaluate the efficacy of oral bithionol as a treatment for fascioliasis.
- To assess the utility of the double diffusion precipitin test in diagnosing fascioliasis.
Main Methods:
- Clinical case series of five patients with fascioliasis.
- Treatment administered: oral bithionol.
- Diagnostic tool: double diffusion precipitin test.
- Epidemiological investigation to identify the source of infection.
Main Results:
- Patients presented with malaise, pruritus, right hypochondrium pain, eosinophilia, elevated serum gamma globulin, and pyrexia.
- Four out of five patients treated with oral bithionol achieved complete recovery.
- The double diffusion precipitin test proved to be a rapid and simple diagnostic method.
- Infection was traced to consumption of wild watercress from a farm ditch.
Conclusions:
- Oral bithionol demonstrates significant efficacy in treating human fascioliasis.
- The double diffusion precipitin test is a valuable tool for rapid fascioliasis screening.
- Wild watercress contaminated by Fasciola eggs is a potential source of human infection.
Related Concept Videos
Rocky Mountain Spotted Fever
Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

